AI Terminal
Galenica AG
Capital/Financing Update • Nov 10, 2025
883_rns_2025-11-10_72b7c323-aec0-4b7c-9862-aa35d3464a47.html
Capital/Financing Update
Open in ViewerOpens in native device viewer
News Details
Corporate | 10 November 2025 17:55
Galenica successfully places a bond of over CHF 250 million
Galenica AG / Key word(s): Bond
Galenica successfully places a bond of over CHF 250 million
10.11.2025 / 17:55 CET/CEST
Press release
Today, Galenica successfully placed a fixed rate bond of over CHF 250 million. The bond has a term of 7 years and an annual coupon of 1.08%. The proceeds from the transaction will be used to repay the bridge financing related to the acquisition of the Labor Team Group as well as for general corporate purposes. With this new bond, Galenica is reducing its short-term financial liabilities and securing its long-term financing. The term until 2032 ideally complements the terms of the outstanding bonds from 2026 (CHF 180 million, coupon 1.0%), 2029 (CHF 240 million, coupon 2.35%) and 2031 (CHF 100 million, coupon 1.65%).
UBS is acting as sole lead manager for the issue. An application will be made for the bond to be admitted to trading on the SIX Swiss Exchange.
Dates for the diary
| 22 January 2026 | Galenica Group sales update 2025 |
| 10 March 2026 | Galenica Group annual results 2025 |
| 21 April 2026 | Annual General Meeting of Galenica Ltd. |
For further information, please contact:
| Media Relations: Tel. +41 58 852 85 17 E-Mail: [email protected] |
Investor Relations: Tel. +41 58 852 85 31 E-mail: [email protected] |
Welcome to the Galenica network!
Around 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally.
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information about Galenica can be found at www.galenica.com .
End of Media Release
View original content: EQS News
| Language: | English |
| Company: | Galenica AG |
| Untermattweg 8 | |
| 3027 Bern | |
| Switzerland | |
| Phone: | +41 058 852 81 11 |
| E-mail: | [email protected] |
| Internet: | https://www.galenica.com |
| ISIN: | CH0360674466 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2226996 |
| End of News | EQS News Service |
2226996 10.11.2025 CET/CEST